Cargando…
P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE
Autores principales: | Pezzullo, Luca, Giudice, Valentina, D’addona, Matteo, Buonanno, Maria Teresa, Novellis, Danilo DE, Ferrara, Idalucia, Fontana, Raffaele, Guariglia, Roberto, Luponio, Serena, Martorelli, Maria Carmela, Mettivier, Laura, Serio, Bianca, Selleri, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429923/ http://dx.doi.org/10.1097/01.HS9.0000973000.81676.fe |
Ejemplares similares
-
P1544: IMPACT OF SARS-COV 2 INFECTION, IN TREATED NHL-B AND HD, AFTER VACCINATION AND PREVENTIVE THERAPY WITH ANTIBODIES: OUR EXPERIENCE
por: Pezzullo, Luca, et al.
Publicado: (2023) -
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens
por: Pezzullo, Luca, et al.
Publicado: (2021) -
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
por: De Novellis, Danilo, et al.
Publicado: (2022) -
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery
por: D’Addona, Matteo, et al.
Publicado: (2023) -
Post-therapy B Regulatory Cells Might early Predict Relapse in Hodgkin Lymphoma
por: Giudice, Valentina, et al.
Publicado: (2022)